Lucera Erick — SEC Form 4 filings
SEC reporting owner CIK 1697616. 17 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-03-05 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 39,266 shares, $15,565 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 37,780 shares, $361,110 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 43.
- Largest priced transaction: sale of 22,337 shares @ $5.61 ($125,404) in Editas Medicine, Inc., filed 2024-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | 6 | — | 4 legs · 11,334 sh · $228,676 | 4 |
| Editas Medicine, Inc. (EDIT) | EVP, CHIEF FINANCIAL OFFICER | 4 | — | 2 legs · 26,446 sh · $132,434 | 5 |
| Beyond Air, Inc. (XAIR) | Director | 5 | 1 leg · 39,266 sh · $15,565 | — | 32 |
| SAB Biotherapeutics, Inc. (SABS) | Director | 2 | — | — | 2 |
Form 4 filings — Lucera Erick
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 1,797 @ $26.28 | EDGAR |
| 2026-06-26 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,362 @ $20.37 | EDGAR |
| 2026-05-14 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 1,448 @ $18.36 | EDGAR |
| 2026-04-03 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 5,727 @ $18.64 | EDGAR |
| 2026-02-17 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | SAB Biotherapeutics, Inc. (SABS) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Beyond Air, Inc. (XAIR) | Disposition to issuer (D): 2,250 (derivative) · Grant/award (A): 2,250 (derivative) · Disposition to issuer (D): 2,000 (derivative) · Grant/award (A): 2,000 (derivative) · Disposition to issuer (D): 1,500 (derivative) · Grant/award (A): 1,500 (derivative) · +10 more | EDGAR |
| 2025-04-01 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 66,100 @ $0 · Grant/award (A): 214,500 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-03-27 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 275,100 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 4,109 @ $1.71 | EDGAR |
| 2024-11-26 | 4 | Beyond Air, Inc. (XAIR) | Disposition to issuer (D): 45,000 (derivative) · Grant/award (A): 45,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Grant/award (A): 40,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Grant/award (A): 30,000 (derivative) · +8 more | EDGAR |
| 2024-08-15 | 4 | Beyond Air, Inc. (XAIR) | Purchase (P): 39,266 @ $0.40 | EDGAR |
| 2024-07-17 | 4 | SAB Biotherapeutics, Inc. (SABS) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 22,337 @ $5.61 | EDGAR |
| 2024-03-21 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 35,300 @ $0 · Grant/award (A): 25,966 @ $0 · Grant/award (A): 106,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1697616 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →